HSMTX
Price
$13.68
Change
-$0.59 (-4.13%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

HSMTX vs VSIAX

Header iconHSMTX vs VSIAX Comparison
Open Charts HSMTX vs VSIAXBanner chart's image
Hartford Small Cap Value R5
Price$13.68
Change-$0.59 (-4.13%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
HSMTX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HSMTX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSMTX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. HSMTX (135M). VSIAX pays higher dividends than HSMTX: VSIAX (2.01) vs HSMTX (1.49). HSMTX was incepted earlier than VSIAX: HSMTX (13 years) vs VSIAX (13 years). HSMTX is a more actively managed with annual turnover of: 52.00 vs. VSIAX (16.00). HSMTX has a lower initial minimum investment than VSIAX: HSMTX (0) vs VSIAX (3000). HSMTX (16.76) and VSIAX (16.23) have marching annual gain over last year. VSIAX return over 5 years is better than : 52.83 vs. HSMTX (39.44).
HSMTXVSIAXHSMTX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD15.08115.031100%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets135M63B0%
Annual Yield % from dividends1.492.0174%
Returns for 1 year16.7616.23103%
Returns for 3 years12.1520.6759%
Returns for 5 years39.4452.8375%
Returns for 10 years17.57105.6517%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics